Their study, published in Proceedings of the National Academy of Sciences, reveals a drug combination that performs better ...

Management of influenza has become more complicated due to growing resistance to oseltamivir, according to presentations at the Seasonal & Pandemic Influenza 2009 Symposium, sponsored by the ...

Clinical evidence of Tamiflu (oseltamivir; Roche) resistance has been confirmed in patients infected with the novel avian H7N9 flu, as published online in The Lancet. A case series was conducted ...

In 26% of reported instances of oseltamivir resistance, there has been an association with treatment, whereas 6% have been associated with postexposure prophylaxis. 6 During the course of the pandemic ...

"You see this problem of oseltamivir resistance often in bone marrow or organ-transplant patients." Immunosuppressed patients are especially susceptible. "The 2009 flu pandemic was the wake-up call.

Tamiflu resistance in some swine flu patients with weakened immune systems does not seem to reflect a major change in the virus's susceptibility to the frontline drug, according to the World ...

New data published by the World Health Organisation (WHO) has confirmed a low frequency of resistance to Tamiflu (oseltamivir) over 3 influenza seasons (2003 – 2006).

References 1. Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009. Wkly Epidemiol Rec 2009;84:453-459 ...

In addition to oseltamivir, GSK have an antiviral, zanamivir (Relenza), that has been shown to have efficacy against H5N1. Zanamivir is a nasal spray however, not a pill and is not available in ...

Of these, 759 were administered oseltamivir monotherapy (Tamiflu, Roche). After day 1, emergent resistance was detected in 19 patients with influenza A who received oseltamivir.

Avian influenza strain H1N1 with the OC resistance mutation (NA-H274Y) has been found to retain resistance even when the environment did not contain oseltamivir carboxylate, suggesting maintained ...